Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy

Richard T. Davey*, Peter E. Pertel, Alice Benson, Delanie J. Cassell, Brian G. Gazzard, Mark Holodniy, Jacob P. Lalezari, Yves Levy, Ronald T. Mitsuyasu, Frank J. Palella, Richard B. Pollard, Prabhu Rajagopalan, Michael S. Saag, Robert A. Salata, Beverly E. Sha, Shurjeel Choudhri

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences